Category: Tandem Diabetes Care Inc.Syndicate content

Diabetes: Tandem inks Tidepool deal

November 26, 2014 by Mark Hollmer

Tandem Diabetes teams with a non-profit to boost access to a diabetes data through an open-source software platform.

Diabetes: Tandem inks Tidepool deal

Tandem Diabetes slides hard on growing insulin cartridge recall

January 21, 2014 by Arezu Sarvestani

Tandem Diabetes' shares lose about 7% in morning trading after the company widens its insulin cartridge recall to include older units.

Tandem Diabetes slides hard on growing insulin cartridge recall

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Tandem recalls insulin cartridges over leak risk

January 13, 2014 by Arezu Sarvestani

Tandem Diabetes recalls more than 4,700 boxes of insulin cartridges designed for use with its t:slim insulin pump over concerns that the cartridges may leak and result in over- or under-doses of insulin.

Diabetes: Tandem recalls insulin cartridges over leak risk

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Tandem Diabetes closes $138M IPO

November 20, 2013 by Brad Perriello

Tandem Diabetes Care says it sold all 9.2 million shares offered in its initial public offering at $15 per share, raising $138 million.

Tandem Diabetes closes $138M IPO

Tandem Diabetes Care (NSDQ:TNDM) closed its initial public offering yesterday after selling all 9.2 million shares on offer for $15 apiece, raising $138 million.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Underwriters add $18M to Tandem Diabetes IPO

November 15, 2013 by Brad Perriello

The underwriters of Tandem Diabetes Care's initial public offering exercise an over-allotment of 1.2 million shares, adding $18 million to the IPO.

Underwriters add $18M to Tandem Diabetes IPO

 Tandem Diabetes Care (NSDQ:TNDM) said today that the underwrites of its initial public offering picked up a 1.2 million-share over-allotment at $15 per share, adding $18 million to the IPO's value.

UPDATE: Tandem Diabetes shares close 28% above IPO price

November 14, 2013 by Brad Perriello

Shares of Tandem Diabetes Care close 28% above their $15 offering price in their 1st day of public trading.

UPDATE: Tandem Diabetes shares close 28% above IPO price

Shares of Tandem Diabetes Care (NSDQ:TNDM) closed up some more than 28% above their offering price today after the medical device company's initial public offering debuted on the NASDAQ exchange.

BREAKING: Tandem Diabetes shares surge 30% above IPO price

November 14, 2013 by Brad Perriello

Shares of Tandem Diabetes Care gain on the launch of its initial public offering, with shares opening at $19.40 apiece, nearly 30% ahead of the price Tandem set yesterday.

BREAKING: Tandem Diabetes shares surge 30% above IPO price

Shares of Tandem Diabetes Care (NSDQ:TNDM) are up some 30% today after the medical device company's initial public offering debuted on the NASDAQ exchange.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp